Cited in:


This article has been cited by:

  1. 1
    B. Trabert, R. B. Ness, W.-H. Lo-Ciganic, M. A. Murphy, E. L. Goode, E. M. Poole, L. A. Brinton, P. M. Webb, C. M. Nagle, S. J. Jordan, H. A. Risch, M. A. Rossing, J. A. Doherty, M. T. Goodman, G. Lurie, S. K. Kjaer, E. Hogdall, A. Jensen, D. W. Cramer, K. L. Terry, A. Vitonis, E. V. Bandera, S. Olson, M. G. King, U. Chandran, H. Anton-Culver, A. Ziogas, U. Menon, S. A. Gayther, S. J. Ramus, A. Gentry-Maharaj, A. H. Wu, C. L. Pearce, M. C. Pike, A. Berchuck, J. M. Schildkraut, N. Wentzensen, Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium, JNCI Journal of the National Cancer Institute, 2014, 106, 2, djt431


  2. 2
    L. Baandrup, S. Friis, C. Dehlendorff, K. K. Andersen, J. H. Olsen, S. K. Kjaer, Prescription Use of Paracetamol and Risk for Ovarian Cancer in Denmark, JNCI Journal of the National Cancer Institute, 2014, 106, 6, dju111


  3. 3
    Louise Baandrup, Mette T. Faber, Jane Christensen, Allan Jensen, Klaus K. Andersen, Søren Friis, Susanne K. Kjær, Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies, Acta Obstetricia et Gynecologica Scandinavica, 2013, 92, 3